ClinicaliQ Trial Snapshot
- The Ailliance Post-Market Clinical Study — Recruiting • Non-phase study • Oncology • NCT05856370.
- What is being tested: Post-market performance and safety data for Medtronic devices used in cranial and spinal surgical procedures, with patient follow-up extending to 24 months post-operatively.
- Patient eligibility overview: Subjects are enrolled following cranial and/or spinal surgery where indicated for Medtronic device implantation, with standardised postoperative monitoring protocols across the study period.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.
Eligibility Snapshot
- :
- Subject provides written informed consent per institution and/or geographical requirements.
- Subject is intended to receive or be treated with an eligible Medtronic Cranial and Spinal Technology (CST) device(s) (see product appendices), used alone or in combination, for a cranial and/or spinal indication(s).
- Subject is at least 18 years of age or minimum legal age as required by local regulations.
- Subject agrees to complete all required assessments per the Schedule of Events.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.